SANTARIS PHARMACEUTICALS
Similar Organizations
Aju Pharma
South Korean pharmaceutical company.
More informations about "Santaris Pharmaceuticals"
Santaris Pharma - Crunchbase Company Profile
Santaris Pharma A/S is a privately held clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies. The …See details»
Santaris Pharma - Gilde Healthcare
Santaris Pharma discovers and develops RNA-targeted therapies to treat infectious diseases and metabolic disorders. Through its partnerships with pharmaceutical companies, Santaris covers a range of therapeutic areas …See details»
Santaris Pharmaceuticals - Crunchbase Company Profile & Funding
Organization. Santaris Pharmaceuticals . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. A biopharmaceutical company. …See details»
Roche returns to gene silencing with Santaris acquisition
Aug 6, 2014 Roche has just announced a $450m deal to acquire Danish company Santaris Pharma, a specialist in a form of antisense therapy that switches off a gene by interacting with …See details»
Roche to acquire Santaris Pharma to expand discovery and …
Aug 4, 2014 Santaris Pharma's innovation and leadership position has attracted multiple collaborations with leading global pharmaceutical companies. Founded in 2003, Santaris …See details»
Santaris Pharma - Products, Competitors, Financials, Employees ...
Santaris Pharma is a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies. The LNA Drug Platform and Drug Discovery Engine …See details»
Santaris Pharma - VentureRadar
Santaris Pharma A/S is a clinical stage biopharmaceutical company developing next generation RNA-silencing drugs for the treatment of cancer and metabolic diseases. The company, which …See details»
Santaris Pharma - Sunstone
Santaris Pharma A/S (Hoersholm, Denmark) was a platform company stabilizing oligonucleotides using their LNA technology to enable the oligonucleotide’s use in therapeutic products. Upon a successful double track process with full filing of …See details»
Santaris Pharma - Funding, Financials, Valuation & Investors
Santaris Pharma is a biopharmaceutical company focused on the discovery and development of RNA-targeted therapies. New. Resources. Advanced Search. Start Free Trial . ... How much …See details»
Roche continues dealmaking with acquisition of Santaris
Aug 4, 2014 Roche is to buy Santaris Pharma for up to $450m in the latest piece of dealmaking by the Swiss pharmaceuticals group. Roche said that the privately held Danish biotech group’s …See details»
Roche's pRED buys out Santaris in $450M RNA acquisition
Aug 4, 2014 Roche's European-based R&D arm pRED has closed a deal to buy Denmark's Santaris Pharma, paying $250 million upfront with another $200 million up for grabs in …See details»
Roche Bags Santaris Pharma A/S In Deal Worth $450 Million
Aug 4, 2014 Santaris Pharma is developing a diverse pipeline of LNA therapeutics that influence the production or activity of select RNA targets to address diseases that are difficult-to-treat …See details»
Santaris Pharma - PitchBook
Santaris Pharma General Information Description. Developer of ribonucleic acid (RNA) targeted therapies. The company's Locked Nucleic Acid (LNA) Drug Platform and Drug Discovery …See details»
Santaris Pharma - Gilde Healthcare
Santaris Pharma erforscht und entwickelt RNS-gerichtete Therapien für die Behandlung von Infektionskrankheiten und Stoffwechselstörungen. Durch Partnerschaften mit Pharma …See details»
Santaris Pharma Begins Human Clinical Testing of the World's First ...
About Santaris Pharma Santaris Pharma is a Danish clinical stage biopharmaceutical company. The Company was formed in 2003 and has the exclusive rights to LNA technology, a 3rd …See details»
Roche to acquire Santaris Pharma to expand discovery and …
Aug 5, 2014 Santaris Pharma A/S uses its proprietary Locked Nucleic Acid (LNA) platform and tissue-targeting expertise to pioneer next-generation antisense product candidates. Santaris …See details»
Santaris Pharma A/S and miRagen Therapeutics, Inc. Form …
Jun 23, 2010 The unique combination of pharmaceutical properties, small size and very high affinity of LNA-based drugs developed utilizing Santaris Pharma A/S LNA Drug Platform …See details»
Santaris Pharma A/S Advances Miravirsen, The First microRNA …
Sep 23, 2010 Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced that it has advanced …See details»
SANTARIS PHARMA – New data show breakthrough microRNA …
The World Health Organization estimates about 3% of the world’s population has been infected with HCV and that some 170 million are chronic carriers at risk of developing liver cirrhosis …See details»
Novartis receives FDA accelerated approval for Vanrafia® …
Apr 3, 2025 Ad hoc announcement pursuant to Art. 53 LR. Vanrafia can be seamlessly added to supportive care in IgAN and used as a foundational therapy with no requirement for a REMS …See details»